| 前收盘价格 | 7.64 |
| 收盘价格 | 7.55 |
| 成交量 | 726,874 |
| 平均成交量 (3个月) | 799,941 |
| 市值 | 611,895,616 |
| 市盈率 (P/E TTM) | 71.55 |
| 预期市盈率 (P/E Forward) | 66.23 |
| 价格/销量 (P/S) | 6.23 |
| 股市价格/股市净资产 (P/B) | 13.39 |
| 52周波幅 | |
| 利润日期 | 6 May 2025 - 12 May 2025 |
| 营业毛利率 | 8.59% |
| 营业利益率 (TTM) | 24.42% |
| 稀释每股收益 (EPS TTM) | 0.110 |
| 季度收入增长率 (YOY) | 37.40% |
| 季度盈利增长率 (YOY) | 6,197.40% |
| 总债务/股东权益 (D/E MRQ) | 5.75% |
| 流动比率 (MRQ) | 3.57 |
| 营业现金流 (OCF TTM) | 12.11 M |
| 杠杆自由现金流 (LFCF TTM) | 9.61 M |
| 资产报酬率 (ROA TTM) | 7.84% |
| 股东权益报酬率 (ROE TTM) | 22.94% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Packaged Foods (US) | 混合的 | 看跌 |
| Packaged Foods (全球的) | 混合的 | 混合的 | |
| 股票 | ChromaDex Corporation | 看涨 | 看涨 |
AIStockmoo 评分
1.3
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.5 |
| 平均 | 1.25 |
|
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment. |
|
| 部门 | Consumer Defensive |
| 行业 | Packaged Foods |
| 投资方式 | Small Core |
| 内部持股比例 | 34.79% |
| 机构持股比例 | 30.00% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 11.00 (HC Wainwright & Co., 41.94%) | 购买 |
| 中 | 9.55 (23.23%) | |
| 低 | 8.10 (Ladenburg Thalmann, 4.52%) | 购买 |
| 平均值 | 9.55 (23.23%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 8.25 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Mar 2025 | 11.00 (41.94%) | 购买 | 7.94 |
| 10 Mar 2025 | 11.00 (41.94%) | 购买 | 7.88 | |
| Ladenburg Thalmann | 05 Mar 2025 | 8.10 (4.52%) | 购买 | 8.55 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合